Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether green tea extract can slow progression of prostate cancer in men under close monitoring; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING